• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT HAVAB-M REAGENT KIT; HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT HAVAB-M REAGENT KIT; HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY) Back to Search Results
Catalog Number 06C30-22
Device Problem False Negative Result (1225)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/30/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event Description
The customer stated that results using the architect havab-igm assay have increased slightly since the customer started using new reagent lot 19112be00.Data for one sample was provided.Sample id6000059566: 0.88 s/co grayzone reactive, 0.9 s/co grayzone reactive and 0.92 s/co grayzone reactive.Grayzone range is 0.8 - 1.2 s/co.The customer received new reagent lot 19467be00 and retested the sample.The retest result was 0.6 s/co negative.The sample was tested at another laboratory and the result was positive.No adverse impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for false non-reactive results for one sample tested with the architect havab igm assay included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and testing of retained kits with the complaint lot numbers.Trending review determined no adverse trend for the issue for the product.Device history record review did not identify any non-conformances or deviations with the likely cause lot and complaint issue.Inhouse testing of retained kits of the complaint lot number and testing of a commercially available seroconversion panel (biomex scp-hav-001) determined that the sensitivity performance is not negatively impacted.Based on the investigation, no systemic issue or deficiency with the architect havab igm reagent lot was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-M REAGENT KIT
Type of Device
HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY)
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10953341
MDR Text Key232569335
Report Number3002809144-2020-01162
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/05/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/12/2021
Device Catalogue Number06C30-22
Device Lot Number19467BE00
Was Device Available for Evaluation? No
Date Manufacturer Received01/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-